The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2026
Evidence-based pharmacological interventions for insomnia: a systematic review on the effects of eszopiclone on insomnia comorbid with mental disturbances.
СтатьяСистематический обзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Palagini Laura, Dell'Osso Bernardo M, Ferini Strambi Luigi, Liguori Claudio, Martinotti Giovanni, Nobili Lino, Sani Gabriele, Fiorillo Andrea
Аннотация
OBJECTIVES: Insomnia is a common sleep disorder frequently co-occuring with psychiatric disturbances. Current research regarding the efficacy of sedative-hypnotic medications within psychiatric contexts underscores the need for further investigation in this domain. This review summarises pertinent findings that focus on eszopiclone, the latest Z-drug, in the treatment of insomnia linked to mental disorders.
METHODS: Initially, literature on mechanism and effects of eszopiclone on GABAergic transmission, sleep regulation and neurogenesis were analysed. Subsequently, we conducted a systematic review regarding its application in insomnia comorbid with psychiatric disorders, in accordance with PRISMA guidelines.
RESULTS: Data showed that eszopiclone has a distinctive chemical composition and, although it demonstrates certain pharmacological effects akin to benzodiazepines and other z-drugs, its distinctive structure differentiates it from other sedative-hypnotics. According to the systematic search, 12 articles were identified investigating the use of eszopiclone in psychiatric disorders, including major depression, anxiety and related disorders, as well as schizophrenia.
CONCLUSIONS: Overall data indicated that the use of eszopiclone as an adjunctive treatment for insomnia may alleviates insomnia symptoms and also positively influences depressive, anxiety, and cognitive aspects related to psychiatric disorders.
METHODS: Initially, literature on mechanism and effects of eszopiclone on GABAergic transmission, sleep regulation and neurogenesis were analysed. Subsequently, we conducted a systematic review regarding its application in insomnia comorbid with psychiatric disorders, in accordance with PRISMA guidelines.
RESULTS: Data showed that eszopiclone has a distinctive chemical composition and, although it demonstrates certain pharmacological effects akin to benzodiazepines and other z-drugs, its distinctive structure differentiates it from other sedative-hypnotics. According to the systematic search, 12 articles were identified investigating the use of eszopiclone in psychiatric disorders, including major depression, anxiety and related disorders, as well as schizophrenia.
CONCLUSIONS: Overall data indicated that the use of eszopiclone as an adjunctive treatment for insomnia may alleviates insomnia symptoms and also positively influences depressive, anxiety, and cognitive aspects related to psychiatric disorders.